|
11.
|
|
15 p, 694.5 KB |
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms : results from the EPICOVIDEHA registry
/
Marchetti, Monia (Azienda Ospedaliera Nazionale) ;
Salmanton-García, Jon (University of Cologne, Cologne, Germany) ;
El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ;
Verga, Luisa (Università Milano-Bicocca) ;
Itri, Federico (San Luigi Gonzaga Hospital-Orbassano, Orbassano, Italy) ;
Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion, Prague, Czech Republic) ;
Dávila-Valls, Julio (Hospital Nuestra Señora de Sonsoles (Àvila)) ;
Martín-Pérez, Sonia (Hospital Nuestra Señora de Sonsoles (Àvila)) ;
Van Doesum, Jaap (University Medical Center Groningen, The Netherlands) ;
Passamonti, Francesco (University Insubria, Varese, Italy) ;
Abu-Zeinah, Ghaith (Division of Hematology and Oncology, Weill Cornell Medicine, New York) ;
Farina, Francesca (IRCCS Ospedale San Raffaele, Milan, Italy) ;
López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome) ;
Cattaneo, Chiara (Hematology Unit, ASST-Spedali Civili, Brescia, Italy) ;
Gomes Da Silva, Maria (Portuguese Institute of Oncology, Lisbon, Portugal) ;
Bilgin, Yavuz M. (Department of Internal Medicine, ADRZ, Goes, The Netherlands) ;
Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ;
Petzer, Verena (Medical University of Innsbruck, Austria) ;
Glenthøj, Andreas (Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark) ;
Espigado, Ildefonso (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Buquicchio, Caterina (Ospedale Dimiccoli Barletta, Italy) ;
Bonuomo, Valentina (University of Verona, Italy) ;
Prezioso, Lucia (Hospital University of Parma, Italy) ;
Meers, Stef (AZ KLINA, Brasschaat, Belgium) ;
Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Bergantim, Rui ;
Jakšić, Ozren ;
Čolović, Natasha ;
Blennow, Ola ;
Cernan, Martin ;
Schönlein, Martin ;
Samarkos, Michail ;
Mitra, Maria Enza ;
Magliano, Gabriele ;
Maertens, Johan ;
Ledoux, Marie-Pierre ;
Jiménez, Moraima (Hospital Universitari Vall d'Hebron) ;
Demirkan, Fatih ;
Collins, Graham ;
Cabirta, Alba (Hospital Universitari Vall d'Hebron) ;
Gräfe, Stefanie K. ;
Nordlander, Anna ;
Wolf, Dominik ;
Arellano, Elena ;
Cordoba, Raul ;
Hanakova, Michaela ;
Zambrotta, Giovanni ;
Nunes Rodrigues, Raquel ;
Limberti, Giulia ;
Marchesi, Francesco ;
Cornely, Oliver A. ;
Pagano, Livio ;
Universitat Autònoma de Barcelona
Patients with Philadelphia-negative chronic myeloproliferative neoplasms (MPN) typically incur high rates of infections and both drugs and comorbidities may modulate infection risk. The present study aims to assess the effect of immunosuppressive agents on clinical outcomes of MPN patients affected by the coronavirus disease 2019 (COVID-19). [...]
2023 -  10.1177/20406207231154706
Therapeutic Advances in Hematology, Vol. 14 (march 2023)
|
|
|
12.
|
|
10 p, 1.4 MB |
SELNET clinical practice guidelines for bone sarcoma
/
Blay, Jean-Yves (Léon Bérard Center (Lyon)) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Bollard, Julien (Léon Bérard Center) ;
Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ;
Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ;
Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ;
CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ;
Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ;
Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ;
Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ;
Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ;
Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ;
Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ;
Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Dufresne, Armelle (Léon Bérard Center (Lyon)) ;
Eriksson, Mikael (Skane University Hospital (Lund)) ;
Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ;
Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ;
Gouin, François (Léon Bérard Center (Lyon)) ;
Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ;
Karanian, Marie (Léon Bérard Center (Lyon)) ;
Kasper, Bernd (University of Heidelberg (Mannheim)) ;
Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ;
Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ;
Maki, Robert G. (University of Pennsylvania (New York)) ;
Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ;
Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ;
Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ;
Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ;
Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ;
Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ;
Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ;
Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ;
Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ;
Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ;
Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ;
Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ;
Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ;
Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ;
Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685
|
|
|
13.
|
|
16 p, 2.1 MB |
Recent therapeutic advances in urothelial carcinoma : A paradigm shift in disease management
/
Bellmunt, J. (Department of Medical Oncology. Beth Israel Deaconess Medical Center and IMIM-PSMAR Lab. Harvard Medical School) ;
Valderrama, B.P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Puente, J. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Grande, Enrique (MD Anderson Cancer Center Madrid) ;
Bolós, M.V. (Pfizer) ;
Laínez, Nuria (Hospital Universitario de Navarra) ;
Vázquez, S. (Hospital Universitario Lucus Augusti (Lugo)) ;
Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Climent, Miguel Ángel (Department of Medical Oncology. Valencia Institute of Oncology Foundation) ;
Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Arranz, J.Á. (Hospital General Universitario Gregorio Marañón) ;
Durán, Ignacio (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Universitat Autònoma de Barcelona
Management of first-line advanced urothelial carcinoma (UC) has consisted during the past three decades in the administration of platinum-based chemotherapy followed by observation. Despite moderate to high response rates to first-line treatment, most patients will relapse shortly after and the outcomes with subsequent therapies are poor with 5-year overall survival rates of 5% in the pre-immunotherapy era. [...]
2022 - 10.1016/j.critrevonc.2022.103683
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103683
|
|
|
14.
|
|
|
15.
|
|
15 p, 1.0 MB |
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents : a cohort study from the GESMD
/
Vilorio-Marqués, Laura (Instituto de Investigación Sanitaria del Principado de Asturias) ;
Castañón Fernández, Christelle (Instituto de Investigación Sanitaria del Principado de Asturias) ;
Mora, Elvira (Hospital Universitari i Politècnic La Fe (València)) ;
Gutiérrez, Lorena (Hospital Universitario de Canarias (La Laguna)) ;
Rey Bua, Beatriz (Hospital Clínico Universitario) ;
Jiménez Lorenzo, Maria José (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Díaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ;
Vara Pampliega, Miriam (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Molero, Antonieta (Hospital Universitari Vall d'Hebron) ;
Sánchez-García, Joaquín (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Calabuig, Marisa (Hospital Clínic Universitari (València)) ;
Cedena, María Teresa (Hospital Universitario 12 de Octubre (Madrid)) ;
Chen-Liang, Tzu (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Díaz Santa, Johana Alejandra (Institut Catalá de Oncología) ;
Padilla, Irene (Complejo Asistencial Universitario de León) ;
Hernández, Francisca (Hospital Universitario Virgen de las Nieves (Granada)) ;
Díez, Rosana (Hospital Universitario Miguel Servet (Saragossa)) ;
Asensi, Pedro (Hospital Universitari i Politècnic La Fe (València)) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ;
Valcárcel, David (Hospital Universitari Vall d'Hebron) ;
Diez-Campelo, María (Hospital Clínico Universitario (Salamanca)) ;
Bernal, Teresa (Hospital Universitario Central de Asturias. Instituto de Investigación Sanitaria del Principado de Asturias) ;
Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras ;
Universitat Autònoma de Barcelona
Background: The consequences of infectious toxicity of hypomethylating agents (HMAs) on overall survival (OS) of patients diagnosed with high-risk myeloid neoplasms have not been thoroughly investigated. [...]
2022 - 10.1177/20406207221127547
Therapeutic Advances in Hematology, Vol. 13 (2022)
|
|
|
16.
|
|
15 p, 1.8 MB |
COVID-19 infection in adult patients with hematological malignancies : a European Hematology Association Survey (EPICOVIDEHA)
/
Pagano, Livio (Università Cattolica del Sacro Cuore) ;
Salmanton-García, Jon (University of Cologne) ;
Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ;
Busca, Alessandro (AOU Citta' Della Salute E Della Scienza) ;
Corradini, Paolo (University of Milan) ;
Hoenigl, Martin (Medical University of Graz) ;
Klimko, Nikolai (North-Western State Medical University Named After Iliá Ilich Méchnikov (Sant Petersburg, Rússia)) ;
Koehler, Philipp (University of Cologne. Faculty of Medicine) ;
Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ;
Passamonti, Francesco (University of Insubria) ;
Verga, Luisa (Università Milano-Bicocca) ;
Víšek, Benjamin (University Hospital Hradec Kralove (República Txeca)) ;
Ilhan, Osman (Ankara University) ;
Nadali, Gianpaolo (Policlinico Borgo Roma Verona (Verona, Itàlia)) ;
Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ;
Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo) ;
Collins, Graham (NIHR Oxford Biomedical Research Centre) ;
Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Cattaneo, Chiara (ASST-Spedali Civili) ;
Cabirta, Alba (Hospital Universitari Vall d'Hebron) ;
Gomes da Silva, Maria (Portuguese Institute of Oncology) ;
Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ;
van Doesum, Jaap A (University Medical Center Groningen) ;
Ledoux, Marie-Pierre (ICANS) ;
Čerňan, Martin (University Hospital Olomouc (Olomouc, República Txeca)) ;
Jakšić, Ozren (University Hospital Dubrava) ;
Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda (Milà, Itàlia)) ;
Omrani, Ali S. (Communicable Disease Center, Hamad Medical Corporation) ;
Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Kulasekararaj, Austin (King's College London) ;
Valković, Toni (University of Rijeka. Faculty of Medicine) ;
Poulsen, Christian Bjørn (Zealand University Hospital) ;
Machado, Marina (Hospital General Universitario Gregorio Marañón) ;
Glenthøj, Andreas (University of Copenhagen) ;
Stoma, Igor (Gomel State Medical University) ;
Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ;
Piukovics, Klára (University of Szeged. Department of Internal Medicine) ;
Navrátil, Milan (University Hospital Ostrava) ;
Emarah, Ziad (Mansoura University. Oncology Center) ;
Sili, Uluhan (Marmara University) ;
Maertens, Johan (KU Leuven) ;
Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Bergantim, Rui (University of Porto) ;
Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ;
Prezioso, Lucia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ;
Guidetti, Anna (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
del Principe, Maria Ilaria (University of Rome Tor Vergata. Department of Biomedicine and Prevention) ;
Popova, Marina (Pavlov University) ;
De Jonge, Nick (Amsterdam UMC, Location VUmc) ;
Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ;
Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ;
Cuccaro, Annarosa (Azienda USL Toscana NordOvest (Livorno, Itàlia)) ;
Meers, Stef (AZ Klina) ;
Buquicchio, Caterina (Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy) ;
Antić, Darko (University of Belgrade. Faculty of Medicine) ;
Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ;
García-Sanz, Ramón (IBSAL, Centro de Investigación del Cáncer-IBMCC) ;
Biernat, Monika M. (Wroclaw Medical University) ;
Tisi, Maria Chiara (San Bortolo Hospital. Cell Therapy and Hematology) ;
Sal, Ertan (University of Cologne, Faculty of Medicine and University Hospital Cologne. Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases) ;
Rahimli, Laman (University of Cologne. Faculty of Medicine) ;
Čolović, Natasa (University of Belgrade. Faculty of Medicine) ;
Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Tascini, Carlo (Azienda Sanitaria Universitaria del Friuli Centrale (Udine, Itàlia)) ;
Miranda-Castillo, Carolina (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ;
Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina) ;
Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ;
Novák, Jan (University Hospital of Královské Vinohrady) ;
Besson, Caroline (Centre Hospitalier de Versailles) ;
Duléry, Rémy (Sorbonne Université) ;
Lamure, Sylvain (Universite de Montpellier. Departement d'Hematologie Clinique) ;
Nucci, Marcio (Federal University of Rio de Janeiro) ;
Zambrotta, Giovanni (Università Milano-Bicocca) ;
Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ;
Seval, Guldane Cengiz (Ankara University) ;
Bonuomo, Valentina (Policlinico Borgo Roma Verona, Verona, Italy) ;
Mayer, Jiří (University Hospital Brno (República Txeca)) ;
López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo. Hematology and BMT Unit) ;
Booth, Stephen (NIHR Oxford Biomedical Research Centre, Churchill Hospital) ;
Ciceri, Fabio (IRCCS San Raffaele Scientific Institute. Hematology and Bone Marrow Transplantation) ;
Oberti, Margherita (ASST-Spedali Civili) ;
Salvini, Marco (University of Insubria) ;
Izuzquiza, Macarena (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Nunes-Rodrigues, Raquel (Portuguese Institute of Oncology) ;
Ammatuna, Emanuele (University Medical Center Groningen) ;
Obr, Aleš (Palacky University. University Hospital Olomouc) ;
Herbrecht, Raoul (ICANS) ;
Núñez-Martín-Buitrago, Lucía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Mancini, Valentina (ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy) ;
Shwaylia, Hawraa (National Center for Cancer Care and Research, Hamad Medical Corporation) ;
Sciumè, Mariarita (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Essame, Jenna (King's College Hospital NHS Foundation Trust) ;
Nygaard, Marietta (Zealand University Hospital) ;
Batinić, Josip (University of Zagreb. Faculty of Medicine) ;
Gonzaga, Yung (Instituto Nacional Do Cancer. Hematology Service) ;
Regalado-Artamendi, Isabel (Hospital General Universitario Gregorio Marañón) ;
Karlsson, Linda Katharina (University of Copenhagen) ;
Shapetska, Maryia (Scientific and Practical Center for Surgery, Transplantology and Hematology (Mins, Bielorússia)) ;
Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ;
El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ;
Borbényi, Zita (University of Szeged. Department of Internal Medicine) ;
Çolak, Gökçe Melis (Marmara University) ;
Nordlander, Anna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Dragonetti, Giulia (Università Cattolica del Sacro Cuore) ;
Maraglino, Alessio Maria Edoardo (Università Cattolica del Sacro Cuore) ;
Rinaldi, Amelia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ;
De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ;
Cornely, Oliver A. (German Centre for Infection Research (DZIF))
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. [...]
2021 - 10.1186/s13045-021-01177-0
Journal of hematology & oncology, Vol. 14 (october 2021)
|
|
|
17.
|
|
|
18.
|
|
10 p, 631.8 KB |
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL : analysis from the iLLUMINATE study
/
Greil, Richard (Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg. IIIrd Medical Department Paracelsus Medical University) ;
Tedeschi, Alessandra (Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy) ;
Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ;
Anz, Bertrand (Tennessee Oncology. Department of Medical Oncology) ;
Larratt, Loree (University of Alberta Hospital. Department of Clinical Hematology) ;
Simkovic, Martin (University Hospital Hradec Kralove (República Txeca)) ;
Gill, Devinder (Princess Alexandra Hospital. Department of Clinical Hematology) ;
Gribben, John G. (Queen Mary University of London, Barts Cancer Institute. Centre for Haemato-Oncology) ;
Flinn, Ian W. (Sarah Cannon Research Institute/Tennessee Oncology) ;
Wang, Zhengyuan (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ;
Cheung, Leo W. K. (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ;
Nguyen, Aaron N. (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ;
Zhou, Cathy (Pharmacyclics LLC, an AbbVie Company. Biostatistics) ;
Styles, Lori (Pharmacyclics LLC, an AbbVie Company. Clinical Science) ;
Demirkan, Fatih (Dokuz Eylül University. Department of Hematology) ;
Universitat Autònoma de Barcelona
The online version contains supplementary material available at 10. 1007/s00277-021-04536-6.
2021 - 10.1007/s00277-021-04536-6
Annals of Hematology, Vol. 100 (may 2021) , p. 1733-1742
|
|
|
19.
|
|
469.5 KB |
Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes
/
Martin, Roman (University Medical Center Göttingen) ;
Acha, Pamela (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ganster, Christina (University Medical Center Göttingen) ;
Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Dierks, Sascha (University Medical Center Göttingen) ;
Fuster-Tormo, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ademà, Vera (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Gómez-Marzo, Paula (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
De Haro, Nuri (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Solanes, Neus (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Shirneshan, Katayoon (University Medical Center Göttingen) ;
Flach, Johanna (University Medical Center Göttingen) ;
Braulke, Friederike (University Medical Center Göttingen) ;
Schanz, Julie (University Medical Center Göttingen) ;
Kominowski, Arkadiusz (University Medical Center Göttingen) ;
Stromburg, Martin (University Medical Center Göttingen) ;
Brockmann, Alina (University Medical Center Göttingen) ;
Trümper, Lorenz (University Medical Center Göttingen) ;
Sole, F. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Haase, Detlef (University Medical Center Göttingen) ;
Universitat Autònoma de Barcelona
2018 - 10.1002/ajh.25089
American Journal of Hematology, Vol. 93 (april 2018) , p. E152-E154
|
|
|
20.
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
